Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 18.6.2019Mylan Ireland Limited (MNY)2247BQuetiapin Mylan 200 mg tablety s predĺženým uvoľňovaním (tbl plg 60x200 mg (blis.PVC/Al))19.6.2019R
 18.6.2019Viatris Limited (VIM)39932Quetiapine Viatris 200 mg (tbl flm 60x200 mg (blis.PVC/PVDC/Al))19.6.2019R
 18.6.2019Viatris Limited (VIM)92955Zolpidem Viatris 10 mg (tbl flm 20x10 mg (blister PVC/Al))19.6.2019R
 18.6.2019Viatris Limited (VIM)52547Epirubicin Viatris 2 mg/ml (sol inj 1x5 ml/10 mg (liek.inj.skl.))19.6.2019O
 18.6.2019Mylan Ireland Limited (MNY)4703CLinezolid Mylan 600 mg filmom obalené tablety (tbl flm 10x600 mg (blis.OPA/Al/PVC/Al))19.6.2019O
 18.6.2019B.Braun Melsungen AG (BME)05628NuTRIflex Omega plus (emu inf 5x2500 ml (vak.PA/PP - viackomor.))17.6.2019Z
 17.6.2019MERCK spol. s r.o. (MRS)33427Concor COR 2,5 mg (tbl flm 30x2,5 mg (blis.PVC/Al))13.6.2019R
 14.6.2019medac Gesellschaft für klinische Spezialpräparate m.b.H. (MED-2)49594Levofolic 50 mg/ml injekčný alebo infúzny roztok (sol ijf 1x1 ml/50 mg (liek.inj.skl.))19.6.2019O
 14.6.2019medac Gesellschaft für klinische Spezialpräparate m.b.H. (MED-2)51228Paclimedac 6 mg/ml infúzny koncentrát (con inf 1x5 ml/30 mg (liek.inj.skl.))15.8.2019Z
 14.6.2019medac Gesellschaft für klinische Spezialpräparate m.b.H. (MED-2)51229Paclimedac 6 mg/ml infúzny koncentrát (con inf 1x16,7 ml/100 mg (liek.inj.skl.))15.8.2019Z
 14.6.2019medac Gesellschaft für klinische Spezialpräparate m.b.H. (MED-2)5876AAzathioprin medac 25 mg filmom obalené tablety (tbl flm 100x25 mg (blis.PVC/PVDC/Al))15.8.2019Z
 14.6.2019medac Gesellschaft für klinische Spezialpräparate m.b.H. (MED-2)5882AAzathioprin medac 50 mg filmom obalené tablety (tbl flm 100x50 mg (blis.PVC/PVDC/Al))15.8.2019Z
 14.6.2019medac Gesellschaft für klinische Spezialpräparate m.b.H. (MED-2)86630Temomedac 20 mg tvrdé kapsuly (cps dur 5x20 mg (fľa.skl.))15.8.2019Z
 14.6.2019Instituto Grifols, S.A. (GFO)45081Flebogamma DIF 50 mg/ml infúzny roztok (sol inf 1x50 ml/2,5 g (liek.skl.))14.6.2019O
 14.6.2019Viatris Healthcare Limited (VIM-1)86087Thioctacid 600 HR (tbl flm 100x600 mg (liek.skl.hnedá))17.6.2019R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)